Noxopharm (ASX:NOX) Share Price and News - StockTrack

Market Cap (19-Sep) $28,573,130 (896th)	Close (30-Jun) $0.043 0 (0%)	Volume (30-Jun) 1,415,719	Shortsold (5-Nov) 11,657 (0.00%) (566th)
52w High $0.135	52w Low $0.043	P/E -	EPS -0.02

	Subject
	NOX NOX Ann: Noxopharm Updated Corporate Presentation February-March 2021
	1 (current) 2 3
	NOX NOX Ann: Option Underwriting Agreement to Secure Funds
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: Noxopharm CEO Letter to Shareholders February 2021
	NOX NOX Ann: Appendix 4D and Half Year Financial Report
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: LuPIN Survival Outcome Confirmed by Conference Presentation
	NOX NOX Ann: Major Survival Benefit in Prostate Cancer Patients Announced
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: Noxopharm To Present to ShareCafe Hidden Gems Webinar
	NOX NOX Ann: Noxopharm Dec 2020 Quarterly Activities Report & Appendix 4C
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: Updated Share Trading Policy
	NOX NOX Ann: NOXCOVID Study Advances
	NOX NOX Ann: Unlisted Options Expiring 28 February 2021
	NOX NOX Ann: Noxopharm Shareholder Update 2021
	NOX NOX Ann: Federal Government Approved Future Overseas R&D Expenditure
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: Change of Director's Interest Notice - BP
	NOX NOX Ann: Change of Director's Interest Notice - FB
	NOX NOX Ann: Appendix 3G
	NOX NOX Ann: December Investor Webinar Recording
	NOX NOX Ann: Change in substantial holding
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: Noxopharm Corporate Presentation December Investor Webinar
	NOX NOX Ann: Pre-Clinical Breakthrough Discovery Set to Expand Pipeline
	NOX NOX Ann: Noxopharm December Investor Webinar Details
	NOX NOX Ann: Cleansing Statement
	NOX NOX Ann: Proposed issue of Securities - NOX
	NOX NOX Ann: Noxopharm Completes A$23m Placement to Fund Clinical Studies
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: Trading Halt
	NOX NOX Ann: Change of Director's Interest Notice - PM
	NOX NOX Ann: Lapsing of Unlisted Options
	NOX NOX Ann: Change of Director's Interest Notice - GK
	NOX NOX Ann: Cleansing Notice
	NOX NOX Ann: Appendix 2A
	NOX NOX Ann: Appendix 3G
	NOX NOX Ann: Further Independent Support for Veyonda as a Major I-O Drug
	NOX NOX Ann: Noxopharm Annual General Meeting Results
	NOX NOX Ann: Noxopharm 2020 AGM Corporate Update
	NOX NOX Ann: 2020 AGM Chairman's Address

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.09	85,328	-0.01 (6.12%)
12-Sep	$0.10	159,935	0.00 (0.00%)
11-Sep	$0.10	91,048	-0.01 (6.67%)
05-Sep	$0.11	25,837	+0.00 (5.00%)
04-Sep	$0.10	58,056	0.00 (0.00%)
03-Sep	$0.10	0	-0.02 (13.04%)
29-Aug	$0.12	104,400	+0.02 (15.00%)
28-Aug	$0.10	92,406	-0.02 (13.04%)
22-Aug	$0.12	210,721	+0.01 (4.55%)
21-Aug	$0.11	222,009	-0.01 (4.35%)
15-Aug	$0.12	99,897	0.00 (4.17%)
14-Aug	$0.12	10,893	+0.01 (9.09%)
07-Aug	$0.11	234,355	+0.01 (4.76%)
31-Jul	$0.11	86,455	-0.02 (16.00%)
30-Jul	$0.13	795,951	0.00 (0.00%)
5 up, 7 down, and 3 flat days

High $0.05	Low $0.04	Trades 61	Turnover $61,445	Volume 1,415,719
30 June 2023 at 4:10pm

High $0.05	Low $0.04	Trades 61	Turnover $61,445	Volume 1,415,719
30 June 2023 at 4:10pm

Noxopharm Health Care

$0.043 0.002 (4.88%)

$0.043 0.002 (4.88%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices